A Stony Brook, New York resident, Dr. Elliott Bennett-Guerrero, is an alumnus of the Harvard Medical School, where he obtained a doctor of medicine. Dr. Elliott Bennett-Guerrero currently serves as the Medical Director for Perioperative Quality and Patient Safety for Stony Brook Medicine. He has led a few clinical studies dedicated to understanding the coronavirus disease.
In 2020, Stony Brook Medicine designed a clinical trial to aid the speedy recovery of patients from the coronavirus disease. In the first phase, Stony Brook Medicine gathered many convalescent plasma donations from Long Island residents who had tested positive for coronavirus in the past. The renowned healthcare facility hypothesized that the antibodies present in the convalescent plasma of former coronavirus patients could be useful to stop the infection of patients battling the virus. The clinical trial was randomized, and 80 percent of the participants were injected with convalescent plasma, while 20 percent were injected with standard plasma. The trial showed that convalescent plasma administration increased antibodies to the virus that causes COVID-19 (SARS-CoV-2) by 14.4% whereas standard plasma administration led to an 8.6% decrease (p=0.005) in these antibody levels. The study did not show an improvement in clinical outcomes such as time on the ventilator, although it may have been too small to show a small improvement.
0 Comments
A board-certified anesthesiologist, Dr. Elliott Bennett-Guerrero is a professor of anesthesiology and the director of perioperative quality and patient safety at Stony Brook Medicine. Dr. Elliott Bennett-Guerrero currently runs a clinical study which centers on developing a cure for patients infected with the novel coronavirus at Stony Brook Medicine.
In the early months of 2020, Stony Brook initiated a double-blind randomized study to investigate the efficacy of convalescent blood plasma in treating hospitalized patients who are diagnosed with a COVID-19 infection. Convalescent blood plasma is extracted from people who had previously contracted COVID-19 but have fully recovered. To confirm eligibility to donate convalescent blood plasma, each person undergoes a COVID-19 point-of-care-test (a serological test ) to check if their serum has an adequate level of IgG antibodies. They then need to meet routine blood transfusion criteria such as adequate weight and age., and also must be free from transmissible diseases. Since 2015, Dr. Elliott Bennett-Guerrero has served as a vice chairman and professor at Stony Brook Medicine and is an active clinician working in the Intensive Care Unit. Currently, Dr. Elliott Bennett-Guerrero is leading a study to discern if blood plasma from people who have recovered from Covid-19 could possibly be the key to finding a potential cure for the disease.
The federally approved research project aims to determine whether recovered patients have convalescent plasma in their blood that contains antibodies to fight Covid-19 and could contribute to the development of a treatment. Researchers at Stony Brook Medicine, who sought blood donations from Covid-19 survivors, believe that the plasma could help to boost the immune systems of people who are battling Covid-19 and ultimately help them to recover from the disease. Throughout history, antibody-rich plasma has been used to treat disease, such as during the 2014 Ebola outbreak and the 1918 influenza epidemic. |
AuthorDr. Elliott Bennett-Guerrero is both an educator and a vice chairman at Stony Brook Medicine. Archives
June 2022
Categories
All
|